Related Experiment Video
Updated: Apr 8, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Prescription patterns of inhaled corticosteroids for preschool children--A Norwegian register study
Knut Øymar1,2, Ingvild Bruun Mikalsen1, Kari Furu3
1Department of Paediatrics, Stavanger University Hospital, Stavanger, Norway.
Insights
Inhaled corticosteroid (ICS) use in preschool children is high but often short-term, indicating potential overuse for asthma-like symptoms. Guidelines for restrictive ICS use in young children may need better implementation.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Pharmacotherapy
Background:
- Asthma and wheeze symptoms in preschool children often overlap, complicating inhaled corticosteroid (ICS) prescription decisions.
- Previous research indicates potential inappropriate prescribing patterns of ICS in this young age demographic.
- This study examines trends and persistence of ICS use in Norwegian preschoolers from 2004-2013.
Purpose of the Study:
- To analyze time trends in inhaled corticosteroid (ICS) utilization among preschool children in Norway.
- To investigate patterns of ICS use by age, gender, and physician specialty.
- To assess the persistence of ICS treatment throughout the preschool years.
Main Methods:
- Utilized data from the Norwegian Prescription Database for the period 2004-2013.
- Included children aged 5 years or younger prescribed ICS, alone or in combination.
- Analyzed prescription data to determine prevalence, age/gender distribution, and treatment duration.
Main Results:
- One-year prevalence of ICS use was high, peaking in 2010 before declining; highest in 2-year-olds and more common in boys.
- 40-50% of ICS users received only one prescription annually, indicating low treatment persistence.
- General practitioners issued the majority of prescriptions, with their share increasing over time.
Conclusions:
- High prevalence but low persistence of ICS prescriptions suggest frequent use for intermittent asthma-like symptoms in preschoolers.
- Current findings highlight a potential gap in adherence to asthma guidelines recommending restricted ICS use in early childhood.
- Further actions may be necessary to ensure better implementation of established guidelines for ICS therapy in young children.
Background:
Although guidelines for treatment of wheeze and asthma in preschool children are available, symptoms are overlapping and it may be difficult to decide which children should be given inhaled corticosteroids (ICS). Previous studies suggest an inappropriate prescription pattern of ICS in this age group. We studied time trends of ICS use in preschool children in Norway during 2004-2013 by age, gender and physician specialty, and the persistence of ICS use during preschool years.
Methods:
Data were drawn from the Norwegian Prescription Database. The study population consisted of children ≤5 years who were prescribed ICS (alone or in combination) during 2004-2013.
Results:
The one-year prevalence of ICS use was generally high, and increased from 2004 to 2010, but decreased thereafter. The prevalence was highest in 2-year-olds (boys 12.9% and girls 9.3% in 2010) and declined by age, and higher among boys in all ages. 40-50% of ICS users received only one prescription per year. The share of children with persistent use of ICS over several preschool years was low, irrespective of the age at the first prescription. The majority of prescriptions were given by general practitioners, increasing during the study period.
Conclusions:
The prevalence of ICS prescription for preschool children was high, but with low persistence, suggesting that ICS are frequently given for intermittent asthma-like symptoms. Asthma guidelines suggest a restrictive use of ICS during the first years of life, and the results may call for actions to better implement these guidelines.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Inhaled Medications
Drug Dosing: Infants and Children
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

